Stuart Therapeutics
Stuart Therapeutics is a biotech company based in Stuart, Florida, focused on developing innovative therapies, particularly through its PolyCol platform, aimed at addressing unmet needs in ophthalmology. The company boasts a team of seasoned professionals from the pharmaceutical and biotech industries, bringing extensive experience in drug development and strategic business management.
With key leaders such as Executive Chairman Robert O. Baratta, MD, and Chief Science Officer Lukas Scheibler, PhD, Stuart Therapeutics is at the forefront of research and innovation in vision science. The company's Scientific Advisory Board, led by David Calkins, PhD, comprises prominent experts dedicated to advancing the understanding and treatment of retinal diseases and visual disorders.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.